Risk of severe (Grade 3-4) vascular thromboembolic adverse events related to anti-EGFR monoclonal antibodies (cetuximab and panitumumab) regimens administered in solid tumours: a meta-analysis of randomized controlled clinical trials
收藏DataCite Commons2020-08-03 更新2026-05-07 收录
下载链接：
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014009165
下载链接
链接失效反馈官方服务：
资源简介：
Systematic review protocol registration
提供机构：
Centre for Reviews and Dissemination - CRD
创建时间：
2015-08-06
